Drugs / TRISTRONTIUM ALUMINATE
last change Nov 2025 re-read 9 days ago

TRISTRONTIUM ALUMINATE

Developed for
pulpitis

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 4 NCT06435065 Comparator Apr 2024 → Apr 2025 pulpitis DR SURINDER SACHDEVA Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as TRISTRONTIUM ALUMINATE ClinicalTrials.gov intervention name — accepted as the source's own label NCT06435065 ↗